Early Detection
438 articles
Understanding How Super-Enhancers Rev Up Pancreatic Cancer Growth
Researcher Ronald Evans, Ph.D., and his team at the Salk Institute are focusing on how super-enhancers stimulate pancreatic cancer growth.
Lucky to Find It Early
When Jeneen Genna did not feel well her doctor searched until they found pancreatic cancer. The BRCA2 mutation has her in a clinical trial.
A 10-Year Survivor’s Story
Howard Ebert, a 10-year survivor of pancreatic cancer, describes his treatment. He underwent surgery and then chemotherapy and radiation.
The Importance of Clinical Trials
Judith Goldring outlines her treatments for pancreatic cancer using a series of clinical trials, as her cancer progresses.
Barbara J. Kenner, Ph.D.
Barbara Kenner established Kenner Family Research Fund (KFRF) in memory of her husband Peter, who died shortly after he was diagnosed with pancreatic neuroendocrine cancer. The purpose of KFRF is to facilitate the development of an early detection methodology for pancreatic cancer in order to improve survival. Dr. Kenner is a founding partner of Neuropsychological […]
The Link Between Pancreatic Cancer and Diabetes
Dr. Suresh Chari of the Mayo Clinic has spent a good part of his career looking at the relationship between pancreatic cancer and diabetes.
More Research Needed for Pancreatic Cancer Immunotherapy
Dr. Luis Diaz provides a status check for immunotherapy treatments for pancreatic cancer, including an explanation of different types.
AACR Virtual Special Conference on Pancreatic Cancer: Day Two Highlights
Let’s Win and the Lustgarten Foundation present highlights of Day Two of the AACR Virtual Special Conference on Pancreatic Cancer.
PancChat Featured in a Journal Article
PancChat co-host Dr. Niraj Gusani has coauthored an article about the advantages of social media for oncology surgeons.
A Fighting Spirit
Resilience best describes Dr. Errol D. Toulon, Jr., a long-term survivor of lymphoma, pancreatic cancer, and a heart emergency.
Sidney Levinson
Sidney Levinson is a lawyer who specializes in restructuring and special situations. He has practiced for more than 35 years and is currently a partner at Debevoise & Plimpton, a New York-based law firm. He is a fellow in the American College of Bankruptcy and, from 1992 to 1995, served as a trial attorney in […]
Blessed to Be Here and Healthy
Jacqueline Sims-Mayes is blessed to be a pancreatic cancer survivor. Her faith helped her through a difficult recovery from Whipple surgery.
New Cancer Stem Cell Pathway Drug May Change Standard of Care
Dr. Tanios Bekaii-Saab is testing a new drug that works on pancreatic cancer stem cells to make chemotherapy more effective.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
A Clinical Trial Gives Me Hope
When Dennis Rues’s pancreatic cancer recurred, his doctors recommended that he join a clinical trial. Now he’s doing well.